Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Non-Current Debt (2016 - 2026)

Orthopediatrics has reported Non-Current Debt over the past 11 years, most recently at $100.4 million for Q1 2026.

  • For Q1 2026, Non-Current Debt rose 17730.73% year-over-year to $100.4 million; the TTM value through Mar 2026 reached $100.4 million, up 17730.73%, while the annual FY2025 figure was $99.8 million, 36.82% up from the prior year.
  • Non-Current Debt for Q1 2026 was $100.4 million at Orthopediatrics, up from $99.8 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $100.4 million in Q1 2026 and troughed at $563000.0 in Q1 2025.
  • A 5-year average of $39.8 million and a median of $9.6 million in 2024 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: crashed 97.84% in 2023 and later skyrocketed 17730.73% in 2026.
  • Year by year, Non-Current Debt stood at $799000.0 in 2022, then dropped by 18.65% to $650000.0 in 2023, then soared by 11124.0% to $73.0 million in 2024, then soared by 36.82% to $99.8 million in 2025, then rose by 0.57% to $100.4 million in 2026.
  • Business Quant data shows Non-Current Debt for KIDS at $100.4 million in Q1 2026, $99.8 million in Q4 2025, and $99.2 million in Q3 2025.